First Choice Neurology

First Choice Neurology Partners with NeuroDiscovery AI to Advance Neurological Care and Research Nationwide

First Choice Neurology is proud to announce a groundbreaking partnership with NeuroDiscovery AI (NDAI), a national leader in artificial intelligence, data analytics, and clinical dashboarding for neurology. This strategic collaboration brings cutting-edge AI capabilities to our practice and connects us with a nationwide prestigious network of leading outpatient neurology groups. Together, we are working to transform the future of neurology by advancing research, optimizing patient outcomes, and elevating standards of care.

A Commitment to Excellence in Neurology

At First Choice Neurology, our mission has always been to provide compassionate, evidence-based care to patients across Florida and beyond. As a founding partner with NeuroDiscovery AI, we are enhancing our ability to analyze clinical data, track outcomes, and identify meaningful insights to better serve our patients. This partnership enables our physicians and research centers to leverage advanced data tools to make more informed decisions and contribute to impactful research across multiple neurological conditions.

“Joining forces with NeuroDiscovery AI is a major milestone for First Choice Neurology. It strengthens our ability to offer the most advanced and personalized care while actively participating in nationwide efforts to shape the future of neurological medicine.”
— Jose Rocha, Director of Central Business Office, First Choice Neurology

First Choice Neurology and NeuroDiscovery AI Partnership
  
A Shared Vision for the Future

Through this collaboration, First Choice Neurology joins a national alliance of leading neurology practices committed to driving innovation in patient care with the world’s most extensive longitudinal dataset in neurology. Together, we will utilize AI-powered insights to:
• Revolutionize patient care through AI and extensive medical data
• Monitor treatment outcomes in real-time
• Accelerate research and clinical trials
• Discover new biomarkers & novel targets
• Improve care coordination and efficiency

Today, we stand at the forefront of neurological research, armed with:
• The world’s most extensive longitudinal dataset in neurology
• Partnerships with over 470 leading neurology providers across the US
• A comprehensive database consists of multimodal data extracted from 5 M+ patients
• Cutting-edge AI technology to derive meaningful insights from complex data

From diagnosis to treatment and long-term management, our goal is to make neurological care more precise, effective, and patient-centered.

Advancing Care in Key Neurological Areas

Our partnership with NeuroDiscovery AI allows us to focus on several high-impact areas of neurological research and care:

Multiple Sclerosis (MS)
Multiple Sclerosis is a chronic autoimmune disorder affecting the central nervous system. With the help of NeuroDiscovery AI, our MS specialists can track disease progression, evaluate treatment efficacy, and explore new therapeutic options more effectively than ever before.

“The quality and volume of information that NDAI can garner from our records is outstanding. This collaboration provides us with powerful tools to better understand disease patterns and personalize MS treatment strategies. Levels of magnitude are greater than I thought possible. It’s a major leap forward in how we care for our MS patients.”
— Dr. Bernard Gran, Neurologist, First Choice Neurology

Parkinson’s Disease (PD)
Parkinson’s Disease is a progressive neurodegenerative disorder that affects movement, cognition, and quality of life. Through data-driven research, we’re identifying new biomarkers and refining care models that improve long-term outcomes for Parkinson’s patients.

Alzheimer’s Disease (AD)
As one of the leading outpatient neurology groups treating Alzheimer’s and other forms of dementia, First Choice Neurology is at the forefront of clinical care and research. NeuroDiscovery AI will allow us to analyze large-scale data sets, assess the real-world effectiveness of new medications, and contribute to developing novel therapies.

NeuroDiscovery AI offers clinicians and researchers millions of data points to investigate new treatments for neurological disorders. “Let’s say you want to evaluate and identify a group of 100 women, between the ages of 50-65, with a maternal history of dementia, and track their development of cognitive decline. NDAI can generate that data in a minute as opposed to weeks or months. Do you wish to assess associated genetic markers? That would take another minute. And to correlate common MRI patterns would take just another minute.” Dr. Jeff Gelblum believes that “this new computer technology will revolutionize clinical research and treatment protocols.”
— Dr. Jeff Gelblum, Neurologist and national authority on the treatment of Alzheimer’s, First Choice Neurology

Frontotemporal Dementia (FTD)
Frontotemporal Dementia is a lesser-known but equally devastating condition that affects personality, behavior, and language. Through our partnership, we aim to accelerate research into early detection and management, contributing to broader efforts in combating all forms of dementia.

Migraine and Headache Disorders
Migraine is one of the most common neurological disorders, often misunderstood and underdiagnosed. Our migraine specialists are now equipped with enhanced tools to track patient responses to medications and identify patterns that may lead to more effective, personalized treatments.

Autism and Developmental Disorders
Neurodevelopmental conditions like autism require a highly individualized and evidence-based approach. With this partnership, our child neurologists and neuropsychologists will be able to integrate behavioral data and clinical metrics to improve diagnosis and track developmental progress over time.

A Unified Mission

At the heart of this partnership is a shared commitment to improving the lives of patients through advanced technology, collaborative research, and compassionate care. The tools and insights provided by NeuroDiscovery AI empower our physicians to deliver world-class care backed by data, while maintaining the personalized attention each patient deserves.

“This isn’t just about adopting technology—it’s about transforming how we practice neurology. Our clinicians now have access to data and tools that help them deliver even better care to patients across every neurological specialty.”
— Jose Rocha, Director of Central Business Office, First Choice Neurology

Looking Ahead

We believe that the future of neurology lies at the intersection of clinical expertise, innovative technology, and collaborative research. Our partnership with NeuroDiscovery AI marks an exciting step forward in our journey to lead that transformation. We look forward to working with them and changing the world, together.

 

Translate »